ArticleiScience2025
Rational protein engineering using an omni-directional multipoint mutagenesis generation pipeline.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineering high-efficiency mutants of the transposase ISDra2 TnpB via protein-generative models and energy-optimized design.aBIOTECH · 2026Article
- Ancestral Sequence Reconstruction for Novel Bifunctional Glutathione Synthetase with Enhanced Thermostability and Catalytic Efficiency.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Generative models have transformed protein design by enabling the generation of extensive datasets. However, accurate identification of biologically active sequences with specific functions within such data remains a significant challenge. In this study, we present a novel pipeline that integrates models for sequence generation, ranking, and selection to engineer proteins with enhanced properties. Our Omni-Directional Multipoint Mutagenesis (ODM) generation model was developed by refining a pre-trained protein BERT model to produce 100,000 mutant proteins. To evaluate the effects of mutations on protein activity, we utilized the lowest probability prediction across all masked positions as an indicator to rank the mutant sequences. Furthermore, we developed thermostability models to identify protease mutants with improved thermostability and utilized biological indicators to enhance lysozyme activity by introducing additional basic residues. Through two iterative design cycles, we observed that 62.5% of protease mutants exhibited enhanced thermostability, while 50% of lysozyme mutants displayed increased bacteriolytic activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.